A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
Status:
Recruiting
Trial end date:
2026-06-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in
participants with severe asthma. The study will evaluate the incidence of asthma
exacerbations, other pharmacodynamic (PD) parameters such as lung function and asthma
control, and the safety and tolerability of verekitug (UPB-101) compared to placebo.